• Water is the major component in biological specimens,
usually by more than 50 %. • In ordinary ice all of the water molecules are connected by hydrogen bonds, six molecules forming a hexagonal ring resembling that of cyclohexane. • By means of hydrogen bonding the water molecules interact with each other and with almost all molecules of biological interest. • The hydrogen bond energy contributes substantially to solvation enthalpies. • Liquid water is the most mobile component in biological systems. • The main task of cryofixation is to keep the water at the same place it occupied at room temperature. Fig. A) Lattice structure of hexagonal ice, showing the 6- membered rings of water molecules. B) A structural element in liquid water. • Cryopreservation is the use of very low temperatures to preserve structurally intact living cells and tissues. • Unprotected freezing is normally lethal. • Freezing injury-ice crystals pierce or tease the cells. • It destroyes them by direct mechanical action, or that damage is from secondary effects via changes in the composition of the liquid phase. • In the specific case of cryofixation, cooling of the specimen gives rise to ultrastructural changes by destabilizing the original structure in the sense of thermodynamics. • At the same time, cooling tends to slow down any reaction rates which might lead to artefication, and increases the lifetime of the original structure by depriving the specimen of the activation energy. • Spermatozoa were the first mammalian cells to be cryopreserved successfully. • Cryoprotectants, simply by increasing the total concentration of all solutes in the system, reduce the amount of ice formed at any given temperature. • Cryoprotectants should be biologically acceptable they must be able to penetrate into the cells and have low toxicity. • Many compounds have such properties like glycerol, dimethyl sulfoxide, ethanediol, and propanediol. • If the water permeability of the cell membrane is known it is possible to predict the effect of cooling rate on cell survival. • Ice can be avoided by vitrification - the production of a glassy state that is defined by the viscosity reaching a sufficiently high value to behave like a solid, but without any crystallization. • Cryopreservation is based on the ability of certain small molecules to enter cells and prevent dehydration and formation of intracellular ice crystals, which can cause cell death and destruction of cell organelles during the freezing process. • Glycerol is used primarily for cryoprotection of red blood cells. • DMSO is used for protection of most other cells and tissues. • A sugar called trehalose, which occurs in organisms capable of surviving extreme dehydration, is used for freeze-drying methods of cryopreservation. • Trehalose stabilizes cell membranes and it is particularly useful for the preservation of sperm, stem cells and blood cells. • When cells are brought into a hypertonic glycerol medium, water will leave the cells because of the osmotic pressure difference. • At the same time, glycerol will enter the cells, after a short period of equilibration: cells will regain their original volume. • The amount of ice formed is lower, the unfrozen fraction remains larger, the degree of shrinkage of the cells is limited. • The electrolyte concentration in the unfrozen solution and in the cells will be relatively small. • Most systems of cellular cryopreservation use a controlled- rate freezer. • This freezing system delivers liquid nitrogen into a closed chamber into which the cell suspension is placed. • Careful monitoring of the rate of freezing helps to prevent rapid cellular dehydration and ice-crystal formation. • In general, the cells are taken from room temperature to approximately −90 °C (−130 °F) in a controlled-rate freezer. • The frozen cell suspension is then transferred into a liquid- nitrogen freezer maintained at extremely cold temperatures with nitrogen in either the vapour or the liquid phase. • Hematopoietic stem cells are collected from a patient’s bone marrow prior to treatment with high-dose chemotherapy. • Patient’s cryopreserved cells are thawed and infused back into the body. • The ability to cryopreserve hematopoietic stem cells has greatly enhanced the outcome for the treatment of certain lymphomas and solid tumour malignancies. • In the case of patients with leukemia, their blood cells are cancerous and cannot be used for autologous bone-marrow rescue. • So these patients rely on cryopreserved blood collected from the umbilical cords of newborn infants or on cryopreserved hematopoietic stem cells obtained from donors. • Today there is intense interest in the growth of the cells in tissue culture systems, as well as in the cryopreservation of the cells for future therapy for a wide variety of disorders of the nervous and muscle systems and diseases of the liver and heart. • Cells can live more than a decade if properly frozen. • Certain tissues such as parathyroid glands, veins, cardiac valves, and aortic tissue, can be successfully cryopreserved. Freezing is also used to store and maintain long-term viability of early human embryos, ova (eggs), and sperm. • Research has shown that whole animals frozen in the absence of cryoprotective agents can yield viable cells containing intact DNA upon thawing. • Nuclei of brain cells from whole mice stored at −20 °C (−4 °F) for more than 15 years have been used to generate lines of embryonic stem cells. • With cryopreservation, water is made unavailable to the bacteria by freezing and the dehydrated cells are stored at low temperatures. • Methods can be broadly classed according to the storage temperature; • -20 to -30°C is achievable with standard laboratory freezers. • -70°C with ultra-low temperature freezers • -140 to -196°C with liquid nitrogen. • Storage of cells in the nitrogen vapor phase (-140°C) or the liquid nitrogen phase (-196°C) is increasingly being used. • Storage of cultures in the range of -60 to -80°C will often result in good viability and may be used when liquid nitrogen is not available or in noncritical applications where some loss of culture viability can be tolerated. • Temp. above -30°C give poor results because of the formation of eutectic mixtures and hence the exposure of cells to high salt concentrations. Cryoprotectants • Good solubility in water and low toxicity are two basic requirements for cryoprotectant additives. • Toxicity varies with temperature, concentration, time of exposure, as well as with the particular cell being frozen. • Toxicity of 10 percent DMSO on human lymphocytes at room temperature for 30 min is minimal. • DMSO and glycerol are used in the empirically determined concentration range of 5 percent to 10 percent. • The optimal concentration will depend on the cell, the composition of the freezing mixture, and the cooling rate. • Higher concentrations of DMSO and glycerol were more effective with slower cooling rates. Cryoprotectant removal • In most cases, adequate dilution of cyroprotectant is a better choice than complete removal at culture initiation. • Adverse effects of DMSO on the recovery of cells were absent at dilutions of tenfold or more when 5% DMSO was used in the freeze mixture. • DMSO will also evaporate from the medium at 37° C. • Removal of the cryoprotectant the day after thawing by changing the medium may yield poor results in some circumstances. • Changing the medium too soon could cause a substantial reduction in the number of viable cells needed to start the culture. Thawing • The thawing process is the reverse of freezing. • In general, thawing may be as difficult to control in large volumes as freezing. • Thermal thawing may be conducted using convection heat transfer from air or liquid, steam at a pressure below atmospheric, heat transfer by conduction (heated plates or blocks), heat pipes, or infrared radiation. • Electrical thawing: resistance or dielectric or microwave heating. • The thawing process can be divided into the following steps: • Heating the solid to a thawing temperature plateau • Thawing (melting of ice) • Heating the liquid to a desire temperature Cryotechniques for microscopy • Radiation damage structural (e.g. loss of crystallinity) or compositional (e.g. mass loss) changes by the electron beam. • It’s a serious factor in limiting the amount of microstructural information that can be collected from an electron microscope specimen. • Damage may be reduced or minimized if the physical factors that affect it are well understood. • The photographs taken using a cryomicroscope show at –40°C a uniform structure both in the already dried and in the frozen part. • The development of cryoelectron microscopy techniques has added a new dimension to the problem of radiation damage to organic and biological specimens. • Cryomicroscope studies have the advantage of showing pictures of the structural changes and the frozen product can be freeze-dried in most instruments. Fig. - Scheme of a cryomicroscope. 1 = Objective of the microscope; 2 = cover-glass; 3 = sample; 4 = sample support; 5 = electrical heating; 6 = cooling chamber with LN2 connection; 7 = vacuum connection. • At the present time, low temperature scanning electron microscopy for morphological purposes may be considered to be well established and routine. • Frozen-hydrated bulk samples prepared for SEM can show details of fluid-filled and air-filled spaces which are not readily apparent in fixed and dried specimens. Freeze-drying • Freeze-drying is a process in which frozen material is dried through the sublimation of ice. • Freezing and freeze-drying techniques have become standard methods for the long-term maintenance of bacterial cultures. • The procedure consists of the three stages: • Freezing - Initially the material is frozen, causing a physical separation of the water as ice from the solids. • Sublimation - The ice is removed from the product by direct conversion to vapor (sublimation), energy is required in the form of heat. • Desorption - Following the removal of ice crystals, what remains of the product is a concentrated solute phase which will become, at the end of the process, the freeze-dried material. • Storage of freeze-dried biological material is extremely cost efficient as no expensive and bulky liquid nitrogen containers are necessary. • The material may be stored at ambient temperature and unlike cryogenic storage, there is no risk of equipment malfunction or of personal injury from liquid nitrogen. • Freeze drying is useful for gene banking of genetic resources with the objective of regenerating live animals and recovering lost breeds. • However, freeze drying generally reduces cell viability. • Therefore, standard insemination procedures generally cannot be used for freeze-dried sperm. • However, freeze-dried sperm have been successfully used to produce live offspring using ICSI in mice and rabbits.